BioSpace News Archive

Chinook Therapeutics, Inc. today announced that dosing in the phase 1 clinical trial of CHK-336 in healthy volunteers has been voluntarily paused to allow a thorough investigation of a serious adverse event (SAE) that occurred in a single subject following the first dose in the 125 mg multiple ascending dose (MAD) group.

Impel Pharmaceuticals announced that four Trudhesa® nasal spray abstracts have been selected to be presented at the upcoming American Academy of Neurology Annual Meeting taking place in Boston, MA, April 22-27, 2023.

Avalyn Pharma Inc. reported top-line results from the company’s ongoing open-label extension trial for investigational drug AP01.

Poseida Therapeutics, Inc. today announced that Kristin Yarema , Ph.D., has joined the Company as President, Cell Therapy effective today.

VintaBio, a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck in cell and gene therapy development, emerged from stealth with newly appointed CEO David Radspinner at its helm, $64 million in funding led by Decheng Capital, and a custom-built manufacturing facility in Philadelphia that is open and accepting orders.

Karius® and eGenesis, Inc. a biotechnology company developing human-compatible organs and cells for the treatment of organ failure, today announced a partnership through which the two companies will develop infectious disease diagnostics for xenotransplantation initially from porcine to primates and ultimately to humans.

Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, May 2, 2023.

Shockwave Medical, Inc. today announced the completion of its previously announced acquisition of Neovasc Inc. (“Neovasc”).

Prelude Therapeutics Incorporated today announced details relating to eight abstracts being presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19 in Orlando, Florida.

Surmodics, Inc. today announced that management will participate in the 22nd Annual Needham Virtual Healthcare Conference, which is being held from April 17-20, 2023.